Related Experiment Video
Updated: Jun 16, 2026

Three Laboratory Procedures for Assessing Different Manifestations of Impulsivity in Rats
Published on: March 17, 2019
Yohimbine increases impulsivity through activation of cAMP response element binding in the orbitofrontal cortex
HaoSheng Sun1, Thomas A Green, David E H Theobald
1Department of Psychology, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada.
Stress increases impulsivity, and yohimbine exacerbates this effect by altering cyclic adenosine monophosphate response element binding (CREB) protein activity in the orbitofrontal cortex. This suggests a novel molecular mechanism linking stress and impulsivity.
Area of Science:
- Neuroscience
- Psychiatry
- Molecular Biology
Background:
- Stress significantly impacts psychiatric conditions by increasing impulsivity.
- Norepinephrine and alpha(2) antagonists like yohimbine are key in studying stress responses.
- Yohimbine's effects on impulsivity and anxiety vary across populations, worsening outcomes in bipolar and substance-dependent individuals.
Purpose of the Study:
- To investigate the neurobiological mechanisms underlying yohimbine-induced impulsivity.
- To explore the role of cyclic adenosine monophosphate response element binding (CREB) protein in the orbitofrontal cortex's regulation of impulsivity.
Main Methods:
- Rats were tested for impulsivity using the five-choice serial reaction time test after yohimbine administration.
- CREB protein activity in brain regions regulating impulsivity was assessed.
- Viral-mediated gene transfer was used to manipulate CREB and mCREB expression in the orbitofrontal cortex.
Main Results:
- Yohimbine increased impulsive behavior in rats.
- Yohimbine selectively elevated CREB phosphorylation in the orbitofrontal cortex.
- Modulating CREB activity in the orbitofrontal cortex directly affected yohimbine's impact on impulsivity.
Conclusions:
- A novel molecular pathway involving CREB in the orbitofrontal cortex contributes to stress-sensitive impulsivity.
- These findings offer insights into the neurobiological links between stress, impulsivity, and psychiatric disorders.
Related Concept Videos
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Drugs Affecting Neurotransmitter Release or Uptake
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...

